rs12904 Polymorphism in the 3'UTR of EFNA1 is Associated with Colorectal Cancer Susceptibility in a Chinese Population

  • Mao, Ying-Ying (Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health) ;
  • Jing, Fang-Yuan (Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health) ;
  • Jin, Ming-Juan (Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health) ;
  • Li, Ying-Jun (Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health) ;
  • Ding, Ye (Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health) ;
  • Guo, Jing (Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health) ;
  • Wang, Fen-Juan (Center for Disease Control and Prevention of Xiaoshan) ;
  • Jiang, Long-Fang (Center for Disease Control and Prevention of Xiaoshan) ;
  • Chen, Kun (Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health)
  • Published : 2013.09.30


Accumulated evidence has indicated that Ephrin A1 (EFNA1) is associated with angiogenesis and tumorigenesis in various types of malignancies, including colorectal cancer (CRC). In the current study, we performed an online search using the public microarray database to investigate whether EFNA1 expression might be altered in CRC tissues. We then conducted a case-control study including 306 subjects (102 cases and 204 well-matched controls) in Xiaoshan County to assess any association between genetic polymorphisms in EFNA1 and CRC susceptibility. Searches in the Oncomine expression profiling database revealed EFNA1 to be overexpressed in CRC tissue compared with adjacent normal tissue. The rs12904 G-A variant located in the 3' untranslated region (UTR) of EFNA1 was observed to be associated with CRC susceptibility. Compared with the AA homozygous genotype, those carrying GA genotype had a decreased risk of developing CRC (odds ratio (OR)=0.469, 95% confidence interval (CI): 0.225-0.977, and P=0.043). The association was stronger among smokers and tea drinkers, however, no statistical evidence of interaction between rs12904 polymorphism and smoking or tea drinking on CRC risk was found. Our results suggest that EFNA1 is involved in colorectal tumorigenesis, and rs12904 A>G polymorphism in the 3' UTR of EFNA1 is associated with CRC susceptibility. Larger studies and further mechanistic investigations are warranted to confirm our findings.


EFNA1;single-nucleotide polymorphism;colorectal cancer;susceptibility


Supported by : National Natural Science Foundation of China


  1. Brantley DM, Cheng N, Thompson EJ, et al (2002). Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene, 21, 7011-6.
  2. Abraham S, Knapp DW, Cheng L, et al (2006). Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res, 12, 353-60.
  3. Barrett JC (2009). Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb Protoc, 2009, pdb ip71.
  4. Burk U, Schubert J, Wellner U, et al (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep, 9, 582-9.
  5. Center MM, Jemal A, Ward E (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-4.
  6. Cui XD, Lee MJ, Yu GR, et al (2010). EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma. Int J Cancer, 126, 940-9.
  7. Cummins JM, He Y, Leary RJ, et al (2006). The colorectal microRNAome. Proc Natl Acad Sci U S A, 103, 3687-2.
  8. Dobrzanski P, Hunter K, Jones-Bolin S, et al (2004). Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res, 64, 910-9.
  9. Holzman LB, Marks RM, Dixit VM (1990). A novel immediateearly response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol Cell Biol, 10, 5830-8.
  10. Kaiser S, Park YK, Franklin JL, et al (2007). Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol, 8, R131.
  11. Huxley RR, Ansary-Moghaddam A, Clifton P, et al (2009). The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer, 125, 171-80.
  12. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  13. Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-7.
  14. Landi D, Gemignani F, Pardini B, et al (2012). Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome. Cancer, 118, 4670-0.
  15. Larkin SE, Holmes S, Cree IA, et al (2012). Identification of markers of prostate cancer progression using candidate gene expression. Br J Cancer, 106, 157-5.
  16. Li Y, Nie Y, Cao J, et al (2012). G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer. Mol Carcinog, (in press).
  17. Lips EH, van Eijk R, de Graaf EJ, et al (2008). Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis. BMC Cancer, 8, 314.
  18. Nakamura R, Kataoka H, Sato N, et al (2005). EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci, 96, 42-7.
  19. Nasiri H, Forouzandeh M, Rasaee MJ, et al (2005). Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal, 19, 229-2.
  20. Potla L, Boghaert ER, Armellino D, et al (2002). Reduced expression of EphrinA1 (EFNA1) inhibits three-dimensional growth of HT29 colon carcinoma cells. Cancer Lett, 175, 187-5.
  21. Nicoloso MS, Sun H, Spizzo R, et al (2010). Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res, 70, 2789-8.
  22. Notterman DA, Alon U, Sierk AJ, et al (2001). Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res, 61, 3124-0.
  23. Poliakov A, Cotrina M, Wilkinson DG (2004). Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell, 7, 465-0.
  24. Shi ZZ, Zhang YM, Shang L, et al (2012). Genomic profiling of rectal adenoma and carcinoma by array-based comparative genomic hybridization. BMC Med Genomics, 5, 52.
  25. Yamamoto H, Tei M, Uemura M, et al (2013). Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer. Int J Oncol, 42, 549-5.
  26. Yang L, Belaguli N, Berger DH (2009). MicroRNA and colorectal cancer. World J Surg, 33, 638-6.

Cited by

  1. EphB1 and Ephrin-B, New Potential Biomarkers for Squamous Cell/adenosquamous Carcinomas and Adenocarcinomas of the Gallbladder vol.15, pp.3, 2014,
  2. mRNA–miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation vol.13, pp.10, 2017,
  3. Voltage-gated calcium channels: Novel targets for cancer therapy vol.14, pp.2, 2017,